Ophthalmic compositions and methods for treating ophthalmic...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/573 (2006.01) A61K 9/10 (2006.01) A61K 47/30 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2573668

Compositions, and methods of using such compositions, useful for placement, for example injection, into the interior of human or animal eyes are provided. Such compositions include a therapeutic component, such as one or more corticosteroids, a biocompatible polymeric component, and a solvent component. The composition is in a fluid foiin before placement in the interior of an eye, and becomes less fluid after the composition is placed in the eye to form an extended or delayed release drug delivery element or system. The drug delivery element is foiiued by the dissipation of the solvent from the composition when the composition is placed in the interior of an eye. One example of a composition includes triamcinolone acetonide as a therapeutic agent. A method of treating an ophthalmic condition, or otherwise improving or enhancing vision of a patient, comprises placing the fluid composition in the interior of the eye. The method may be practiced by injecting the fluid composition into the interior of the eye.

L~invention porte sur des compositions et des procédés d~utilisation de telles compositions, servant au placement, par exemple par injection, à l~intérieur des yeux humains ou d~animaux. De telles compositions comportent un composant thérapeutique, comme un ou plusieurs corticostéroïdes, un composant polymère biocompatible et un composant solvant. La composition est sous forme de fluide avant placement à l~intérieur de l~oeil, et devient moins fluide une fois que la composition est placée dans l~AEil pour constituer un élément ou système d~administration de médicament à libération prolongée ou retardée. L~élément d~administration de médicament fait appel à la dissipation du solvant à partir de la composition une fois la composition placée à l~intérieur de l~AEil. Un exemple de composition contient de l~acétonide de triamcinolone comme agent thérapeutique. Un procédé de traitement d~une condition ophtalmique, ou pour améliorer ou augmenter la vision d~un patient de toute autre manière, consiste à mettre la composition de fluide à l~intérieur de l~oeil. Le procédé peut également consister à injecter la composition de fluide à l~intérieur de l~oeil.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Ophthalmic compositions and methods for treating ophthalmic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic compositions and methods for treating ophthalmic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic compositions and methods for treating ophthalmic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1945633

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.